Skip to main content
$75.28 -$4.62 (-5.8%)

04:00 PM EST on 12/01/21

CRISPR Therapeutics (NASDAQ:CRSP)

CAPS Rating: 5 out of 5

Current Price $75.28 Mkt Cap $5.8B
Open $80.47 P/E Ratio 13.64
Prev. Close $75.28 Div. (Yield) $0.00 (0.0%)
Daily Range $75.12 - $81.54 Volume 900
52-Wk Range $75.12 - $220.20 Avg. Daily Vol. 1,614,904

Caps

How do you think NASDAQ:CRSP will perform against the market?

Add Stock to CAPS Watchlist

All Players

438 Outperform
5 Underperform
 

All-Star Players

96 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CRSP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dcclf (< 20)
Submitted November 01, 2019

Crispr Therapeutics AG (CRSP) is a very professional outfit. Since its de novo in late 2016, the company has always presented itself in the most intelligible, concise, and scrupulous manner. From international conference presentations to downloadable… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CRSP VS S&P 500 (SPY)

NASDAQ:CRSP Summary

Fools bullish on NASDAQ:CRSP are also bullish on:

Fools bearish on NASDAQ:CRSP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CRSP.

Recs

0
Member Avatar Car12703 (< 20) Submitted: 10/13/2021 12:08:19 PM : Outperform Start Price: $96.89 NASDAQ:CRSP Score: -26.18

From Fidelity or Zacks October 2021:
Revenue Growth (Last 5 Years) = 23.8%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 1000%
Price/Sales (TTM) = 8.4

This one is very high risk or very high reward. I believe the odds of high reward are at least 50% so I am buying. This is currently a Cathie Wood favorite.

Recs

0
Member Avatar TMFbonefish (43.72) Submitted: 9/30/2021 12:43:07 PM : Outperform Start Price: $112.96 NASDAQ:CRSP Score: -37.83

I really like the way management is monetizing the hyper-competitive SCD/beta area and targeting other more open therapy areas.

Recs

0
Member Avatar CMFConnorAllen (34.46) Submitted: 9/13/2021 11:35:52 AM : Outperform Start Price: $109.88 NASDAQ:CRSP Score: -35.05

Genomics as an industry has the potential to change the world and why not take an industry leader to add some exposure to your portfolio.

Leaderboard

Find the members with the highest scoring picks in CRSP.

Score Leader

CMFMLove

CMFMLove (73.72) Score: +349.24

I'm generally bad at CAPS but I may have gotten this pick right. There's a long way to go, however, until we see commercial results from this technology.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
CMFMLove 73.72 6/13/2017 Outperform 5Y $14.10 +433.90% +84.66% +349.24 1 Comment
Momentum21 33.06 10/24/2016 Outperform 5Y $14.05 +435.80% +109.77% +326.03 0 Comment
Playa14 < 20 6/9/2017 Outperform 5Y $15.13 +397.55% +84.58% +312.98 0 Comment
prankjt17530 43.51 2/13/2017 Outperform 5Y $15.21 +394.94% +94.13% +300.81 0 Comment
SHOPNVDA < 20 6/26/2017 Outperform 5Y $16.84 +347.03% +84.72% +262.31 0 Comment
Capitalism 91.70 5/15/2017 Outperform 5Y $17.05 +341.52% +87.63% +253.89 1 Comment
TMFFishBiz 53.09 11/13/2017 Outperform 5Y $17.91 +320.32% +74.43% +245.90 0 Comment
JF9383 67.18 12/6/2017 Outperform 5Y $18.44 +308.24% +71.39% +236.85 0 Comment
jeepdrew222 67.44 12/12/2017 Outperform 5Y $18.61 +304.51% +69.01% +235.50 0 Comment
portefeuille 98.28 3/27/2017 Outperform 5Y $18.50 +306.92% +94.26% +212.66 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRSP.